GNLX Similar Chart Price Prediction
The price of GNLX is predicted to go up -1.43%, based on the high correlation periods with AES. The similarity of these two price pattern on the periods is 93.21%.
GNLX
AES
Down: -1.43%Similarity: 93.21%
GNLX Revenue Forecast
GNLX EPS Forecast
GNLX FAQs
What is eps forecast for next quarter？
GNLX Analyst's Forecast
Kelsey Goodwin
Guggenheim
Strong Buy
Price Target
$8
Upside
+158.9%
Guggenheim last night initiated coverage of Genelux with a Buy rating and $8 price target. Genelux is a clinical-stage Biotech company leveraging its proprietary Choice platform-derived library of isolated and engineered oncolytic vaccinia virus product candidates, the analyst tells investors in a research note. The firm says that at the stock's current market cap and near-zero enterprise value, there is a positive risk/reward heading into the Phase III PRROC dataset next year.